BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 19855245)

  • 1. Chemokine receptor blockade with a synthetic nonpeptide compound attenuates cardiac allograft vasculopathy.
    Bastani S; Sherman W; Schnickel GT; Hsieh GR; Bhatia R; Fishbein MC; Ardehali A
    Transplantation; 2009 Oct; 88(8):995-1001. PubMed ID: 19855245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The simultaneous blockade of chemokine receptors CCR2, CCR5 and CXCR3 by a non-peptide chemokine receptor antagonist protects mice from dextran sodium sulfate-mediated colitis.
    Tokuyama H; Ueha S; Kurachi M; Matsushima K; Moriyasu F; Blumberg RS; Kakimi K
    Int Immunol; 2005 Aug; 17(8):1023-34. PubMed ID: 16000328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel small-molecule compound targeting CCR5 and CXCR3 prevents acute and chronic allograft rejection.
    Akashi S; Sho M; Kashizuka H; Hamada K; Ikeda N; Kuzumoto Y; Tsurui Y; Nomi T; Mizuno T; Kanehiro H; Hisanaga M; Ko S; Nakajima Y
    Transplantation; 2005 Aug; 80(3):378-84. PubMed ID: 16082334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation/oxidation in chronic rejection: apolipoprotein a-i mimetic peptide reduces chronic rejection of transplanted hearts.
    Hsieh GR; Schnickel GT; Garcia C; Shefizadeh A; Fishbein MC; Ardehali A
    Transplantation; 2007 Jul; 84(2):238-43. PubMed ID: 17667816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The unique target specificity of a nonpeptide chemokine receptor antagonist: selective blockade of two Th1 chemokine receptors CCR5 and CXCR3.
    Gao P; Zhou XY; Yashiro-Ohtani Y; Yang YF; Sugimoto N; Ono S; Nakanishi T; Obika S; Imanishi T; Egawa T; Nagasawa T; Fujiwara H; Hamaoka T
    J Leukoc Biol; 2003 Feb; 73(2):273-80. PubMed ID: 12554804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chemokine receptor antagonist, TAK-779, decreased experimental autoimmune encephalomyelitis by reducing inflammatory cell migration into the central nervous system, without affecting T cell function.
    Ni J; Zhu YN; Zhong XG; Ding Y; Hou LF; Tong XK; Tang W; Ono S; Yang YF; Zuo JP
    Br J Pharmacol; 2009 Dec; 158(8):2046-56. PubMed ID: 20050195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection.
    Yun JJ; Whiting D; Fischbein MP; Banerji A; Irie Y; Stein D; Fishbein MC; Proudfoot AE; Laks H; Berliner JA; Ardehali A
    Circulation; 2004 Feb; 109(7):932-7. PubMed ID: 14757698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a calcineurin inhibitor, FK506, and a CCR5/CXCR3 antagonist, TAK-779, in a rat small intestinal transplantation model.
    Takama Y; Miyagawa S; Yamamoto A; Firdawes S; Ueno T; Ihara Y; Kondo A; Matsunami K; Otsuka H; Fukuzawa M
    Transpl Immunol; 2011 Jul; 25(1):49-55. PubMed ID: 21515370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of chemokine receptor CCR2 and CCR5 expression contributes to simvastatin-induced attenuation of cardiac allograft vasculopathy.
    Yin R; Zhu J; Shao H; Cheng X; Feng X; Li Z; Jing H
    J Heart Lung Transplant; 2007 May; 26(5):485-93. PubMed ID: 17449418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of blocking the chemokine receptors, CCR5 and CXCR3, With TAK-779 in a rat small intestinal transplantation model.
    Xu H; Firdawes S; Yamamoto A; Zhao Y; Ihara Y; Uehara S; Matsunami K; Otsuka H; Fukuzawa M; Miyagawa S
    Transplantation; 2008 Dec; 86(12):1810-7. PubMed ID: 19104427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined CXCR3/CCR5 blockade attenuates acute and chronic rejection.
    Schnickel GT; Bastani S; Hsieh GR; Shefizadeh A; Bhatia R; Fishbein MC; Belperio J; Ardehali A
    J Immunol; 2008 Apr; 180(7):4714-21. PubMed ID: 18354195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking of CCR5 and CXCR3 suppresses the infiltration of macrophages in acute renal allograft rejection.
    Kakuta Y; Okumi M; Miyagawa S; Tsutahara K; Abe T; Yazawa K; Matsunami K; Otsuka H; Takahara S; Nonomura N
    Transplantation; 2012 Jan; 93(1):24-31. PubMed ID: 22124337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.
    van Loosdregt J; van Oosterhout MF; Bruggink AH; van Wichen DF; van Kuik J; de Koning E; Baan CC; de Jonge N; Gmelig-Meyling FH; de Weger RA
    Circulation; 2006 Oct; 114(15):1599-607. PubMed ID: 17015796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of MIG/CXCL9 in cardiac allograft vasculopathy.
    Yun JJ; Fischbein MP; Whiting D; Irie Y; Fishbein MC; Burdick MD; Belperio J; Strieter RM; Laks H; Berliner JA; Ardehali A
    Am J Pathol; 2002 Oct; 161(4):1307-13. PubMed ID: 12368204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rantes production during development of cardiac allograft vasculopathy.
    Yun JJ; Fischbein MP; Laks H; Irie Y; Espejo ML; Fishbein MC; Berliner JA; Ardehali A
    Transplantation; 2001 Jun; 71(11):1649-56. PubMed ID: 11435978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of CXCR3 and CCR5 in allograft rejection.
    Schnickel GT; Hsieh GR; Garcia C; Shefizadeh A; Fishbein MC; Ardehali A
    Transplant Proc; 2006 Dec; 38(10):3221-4. PubMed ID: 17175228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation.
    Suzaki Y; Hamada K; Nomi T; Ito T; Sho M; Kai Y; Nakajima Y; Kimura H
    Eur Respir J; 2008 Apr; 31(4):783-9. PubMed ID: 18094012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR3 antagonism impairs the development of donor-reactive, IFN-gamma-producing effectors and prolongs allograft survival.
    Rosenblum JM; Zhang QW; Siu G; Collins TL; Sullivan T; Dairaghi DJ; Medina JC; Fairchild RL
    Transplantation; 2009 Feb; 87(3):360-9. PubMed ID: 19202440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoprotective gene HO-1 and chronic rejection in heart transplantation.
    Schnickel GT; Hsieh GR; Kachikwu EL; Garcia C; Shefizadeh A; Fishbein MC; Ardehali A
    Transplant Proc; 2006 Dec; 38(10):3259-62. PubMed ID: 17175242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8 lymphocytes are sufficient for the development of chronic rejection.
    Schnickel GT; Whiting D; Hsieh GR; Yun JJ; Fischbein MP; Fishbein MC; Yao W; Shfizadeh A; Ardehali A
    Transplantation; 2004 Dec; 78(11):1634-9. PubMed ID: 15591952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.